Triazoloanilinopyrimidine derivatives for use as antiviral agents

Details for Australian Patent Application No. 2007204227 (hide)

Owner Arrow Therapeutics Limited

Inventors Tiberghien, Nathalie; Pilkington, Christopher John; Fraser, Ian John; Mathews, Neil; Thomas, Alexander James Floyd; Chana, Surinder; Jennens, Lyn; Spencer, Keith Charles

Agent Davies Collison Cave

Pub. Number AU-B-2007204227

PCT Pub. Number WO2007/080401

Priority 0600510.2 11.01.06 GB; 0612116.4 19.06.06 GB

Filing date 11 January 2007

Wipo publication date 19 July 2007

Acceptance publication date 3 March 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/080401 Priority application(s): WO2007/080401

9 October 2008 Amendment Made

  The nature of the amendment is: Amend the priority details from 0612116.4 19 Jan 2006 GB to 0612116.4 19 Jun 2006 GB 2007206793 Saint-Gobain Glass France The nature of the amendment is: Amend the name of the inventor to read FROM: Schall, Gunther TO: Schall, Guenther

3 March 2011 Application Accepted

  Published as AU-B-2007204227

30 June 2011 Standard Patent Sealed

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007204237-Composition, process for preparation and method of use

2007204226-ACE N-domain crystal